Safety and Efficacy of Inhaled Pre-prandial Human Insulin in Type 2 Diabetes

Summary

This trial is conducted in Asia, Europe and Oceania. The aim of this research study is to compare the efficacy of adding inhaled preprandial insulin to glimepiride compared to adding rosiglitazone to glimepiride for the treatment of type 2 diabetes and to verify its safety (hypoglycaemia, pulmonary function, body weight, insulin antibodies and side effects)

Timeline

Start

2006-10-10

Primary completion

2008-03-10

Completion

2008-03-10

Outcome

Outcome not reported

Stopped: “See termination reason in detailed description”

Drugs

Indications